You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18F-fluorodeoxyglucose Positron Emission Tomography (PET)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Computed Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
May 3, 2023

Simultaneous Fluorodeoxyglucose Positron Emission Tomography and

Completed
  • Visual Snow Syndrome
  • simultaneous fluor-18 fluorodeoxyglucose (FDG) positron emission tomography with magnetic resonance imaging (PET/MRI)
  • (no location specified)
Jan 26, 2023

Lung Carcinoma Trial in Philadelphia (Fludeoxyglucose F-18, Positron Emission Tomography, Computed Tomography)

Recruiting
  • Lung Carcinoma
  • Fludeoxyglucose F-18
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Mar 7, 2023

Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)

Completed
Has Results
  • Lung Carcinoma
  • +2 more
  • Computed Tomography
  • +5 more
  • Nashville, Tennessee
  • +1 more
Oct 17, 2022

Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

Recruiting
  • Breast Carcinoma
  • +7 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jan 24, 2023

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,

Recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Spine
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2022

Brain Glioblastoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging)

Completed
  • Brain Glioblastoma
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Cigarette Smoker, Current Smoker, Former Smoker Trial in Palo Alto (Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18

Recruiting
  • Cigarette Smoker
  • +4 more
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 16, 2022

Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)

Completed
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Bone Trial in Houston (Fludeoxyglucose F-18, Magnetic Resonance

Active, not recruiting
  • Metastatic Malignant Neoplasm
  • Metastatic Malignant Neoplasm in the Bone
  • Fludeoxyglucose F-18
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Patients With Idiopathic Dilated Cardiomyopathy Trial in Nantes, Saint Herblain (18F-deoxyglucose (FDG))

Completed
  • Patients With Idiopathic Dilated Cardiomyopathy
  • 18F-deoxyglucose (FDG)
  • Nantes, France
  • +1 more
Jul 22, 2022

Hepatocellular Carcinoma Trial in Toronto (PET MRI)

Active, not recruiting
  • Hepatocellular Carcinoma
  • PET MRI
  • Toronto, Ontario, Canada
    Toronto General Hospital
Oct 31, 2022

Glioblastoma Trial in Los Angeles (Computed Tomography, Fludeoxyglucose F-18, Positron Emission Tomography)

Recruiting
  • Glioblastoma
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 2, 2022

Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell

Active, not recruiting
  • Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
  • +2 more
  • Computed Tomography
  • +7 more
  • Seattle, Washington
  • +1 more
Jul 18, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)

Recruiting
  • Breast Neoplasms
  • +3 more
  • 68Ga-FAPI-46 PET/CT
  • Baku, Azerbaijan
    National Centre of Oncology
Jun 21, 2022

Cervical Cancer Squamous Cell Trial in Toronto (18-FDG PET/CT, DWI, DCE-MRI)

Completed
  • Cervical Cancer Squamous Cell
  • 18-FDG PET/CT, DWI, DCE-MRI
  • Toronto, Ontario, Canada
    University Health Network, The Princess Margaret
Nov 7, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Cardiac Sarcoidosis Trial in Vancouver (18F-Fluorodeoxyglucose (18F-FDG) PET/CT)

Approved for marketing
  • Cardiac Sarcoidosis
  • 18F-Fluorodeoxyglucose (18F-FDG) PET/CT
  • Vancouver, British Columbia, Canada
    BC Cancer Agency
Feb 2, 2022

FDG PET/CT in Breast Cancer Bone Mets

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Bone Metastases
  • FDG PET/CT scan
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Oct 13, 2022

MRI and PET Imaging in Predicting Treatment Response in Stage

Active, not recruiting
  • Cervical Adenocarcinoma
  • +12 more
  • Computed Tomography
  • +5 more
  • Miami, Florida
  • +5 more
Oct 4, 2022

Malignant Tumor Trial in Salt Lake City ([F-18]fluorodeoxyglucose, [F-18]fluorothymidine, Positron Emission Tomography)

Terminated
Has Results
  • Malignant Neoplasm
  • [F-18]fluorodeoxyglucose
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 20, 2021